surgery / knee replacement / hip surgery / intravenous infusion / Gene therapy / total hip replacement / thrombolytic therapy / hip replacement / /
MusicGroup
Board of Directors / /
Organization
Board of Directors Audit Committee Nomination / Center for Transgene Technology and Gene / Vlerick Management School / Remuneration Committee / Nomination Committee / Center for Molecular / Management Committee / Flanders Institute for Biotechnology / University of Antwerp / Vesalius Research Center / Center for Transgene Technology and Gene Therapy / Center for Molecular and Vascular Biology of the KULeuven / University of Leuven / Clay Mathematics Institute / Directors Audit Committee Nomination and Remuneration Committee / /
Person
Patrik De Haes / J.L. Dehaene / S. Van Reet / Chris Buyse / Landon T. Clay / Désiré Collen / Gaston Geenslaan / / /
Position
chairman and Chief Executive Officer (CEO) / Executive Director / Member a Managing / General / Head / Founder / CEO / Professor / President and CEO / Director Finance / general partner / CFO and interim CEO / Chairman / director / internal IP counsel / Non-Executive Director / CFO / Head of Global Insulin Infusion business / /
Product
Avastin / Annual Report / Xa / TB-402 / TB-403 / company / THR-100 / /